Publications 2007-13

2013

 

Lucas-Hourani M, Munier-Lehmann H, Komarova A, Desprès P, Tangy F, Vidalain PO. (2013). High-throughput screening for broad-spectrum chemical inhibitors of RNA viruses. JoVE, In press

 

Lucas-Hourani M., Dauzonne D., Jorda P, Cousin G, Lupan A, Helynck O, Caignard G, janvier G, André G, Escriou N, Desprès P, Jacob Y, Munier-Lehmann H, Tangy F, Vidalain PO. (2013). Inhibition of pyridimine biosynthesis suppresses viral growth through innate immunity. PLoS Pathogens, in press

 

La Ruche G, Dejour-Salamanca D, Bernillon P, Leparc-Goffart I, Ledrans M, Armengaud A, Debruyne M, Denoyel GA, Brichler S, Ninove L, Desprès P, Gastellu-Etchegorry M. (2013). A capture-recapture method for estimating the annual incidence of imported dengue cases in metropolitan France, 2007-2010. Emerg. Infect.Dis., in press

 

Le Coupanec A, Babin D, Fiette L, Jouvion G, Ave P, Misse D, Bouloy M, Choumet V. (2013). Aedes mosquito saliva modulates rift valley Fever virus pathogenicity. PLoS Negl Trop Dis. 7:e2237

 

Brandler S., Ruffié C., Combredet C., Brault JB., Labrousse V., Habel A., Tauber E., Desprès P., Tangy P. (2013). A recombinant measles vaccine expressing Chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus. Vaccine: 31:3718-25

 

Gandini M., Gras C., Leal Azeredo E., Olivieira Pinto LM., Smith N., Desprès P., Venancio da Cunha R., José de Souza L., Fernandes Kubelka C., Herbeuval JP. (2013). Dengue virus activates membrane TRAIL relocalization and IFN-a production by human plasmacytoid dendritic cells in vitro and in vivo. PLoS Negl.Trop.Dis. 7:e2257

 

Joffret ML., Bouchier C., Grandadam M., Zeller H., Maufrais C., Bourhy H., Desprès P., Delpeyroux F., Dacheux L. (2013). Genomic characterization of Sebokele virus 1 (SBKV1) reveals a distinct species among the genus Parechovirus. J.Gen.Virol. 94: 1547-53

 

Larrieu S., Cardinale E., Ocquidant P., Roger M., Lepec R., Delattre H., Camuset G., Desprès P., Brottet E., Charlin C., Michault A. (2013).  A Fatal neuroinvasive West Nile Virus infection in a traveller returning from Madagascar: clinical, epidemiological and veterinary investigations. Am.J.Trop.Med. 89:211-13

 

Berthet N., Paulous S., Coffey L., Frenkiel MP., Moltini I., Tran C., Martheus S., Ottone C., Ungeheuer MN., Renaudat C., Caro V., Dussart P., Gessain A., Desprès P. (2013). Resequencing microarray method for molecular diagnosis of human arboviral diseases. J. Clin. Virol. 56 :322-7

 

Lucas-Hourani M., Lupan A., Desprès P., Thoret S., Pamlard O., Dubois J., Guillou C., Tangy F., Vidalain PO., Munier-Lehmann H. (2013). A Phenotypic Assay to Identify Chikungunya Virus Inhibitors Targeting the Nonstructural Protein nsP2. J.Biomol.Screen 18:172-9

   

 

2012

 

Bahuon, , Desprès P, Pardigon N, Panthier JJ, Cordonnier N, Lowenski S,  Richardson J, Zientara S, Lecollinet S. (2012).  IS-98-ST1 West Nile virus derived from an infectious cDNA clone retains neuroinvasiveness and neurovirulence properties of original virus. PLoS One 7(10): e47666.

 

Choumet V, Attout T, Chartier L, Khun H, Sautereau J, Robbe-Vincent A, Brey P, Huerre M, Bain O. (2012). Visualizing non infectious and infectious Anopheles gambiae blood feedings in naive and saliva-immunized mice.PLoS One. 7:e50464

 

Gad HH, Paulous S, Belarbi E, Diancourt L, Drosten C, Kümmerer BM, Plate AE, Caro V, Desprès P. (2012) The E2-E166K substitution restores Chikungunya virus growth in OAS3 expressing cells by acting on viral entry. Virology 434 : 27-37

 

Lucas-Hourani M, Lupan A, Desprès P, Thoret S, Pamlard O, Dubois J, Guillou C, Tangy F, Vidalain PO, Munier-Lehmann H. (2012). A Phenotypic Assay to Identify Chikungunya Virus Inhibitors Targeting the Nonstructural Protein nsP2. J.Biomol.Screen, in press

 

Fillipone C., Marianneau P., Murri S. , Mollard N., Avsic-Zupane T., Chinikar S., Desprès P., Caro V., Gessain A., Berthet N.,  Tordo N. (2012). Molecular diagnostic and genetic characterization of highly pathogenic viruses: application during Crimean-Congo haemorrhagic fever virus outbreaks in Eastern Europe and the Middle east. Clin. Microbiol Infect. doi: 10.1111/1469-0691.12075.

 

Brandler S, Marianneau P, Loth P, Lacôte S, Combredet C, Frenkiel MP, Desprès P, Contamin H, Tangy F. (2012). Measles vaccine expressing the secreted form of west nile virus envelope glycoprotein induces protective immunity in squirrel monkeys, a new model of west nile virus infection. J.Infect.Dis. 206: 212-9



Bouraï M, Lucas-Hourani M, Gad HH, Drosten C, Jacob Y, Tafforeau L, Cassonnet P, Jones LM, Andrè P, Kümmerer BM, Lotteau, V, Desprès P, Tangy F, Vidalain, PO. (2012). An interactome map of virus infection network. J. Virol. 86: 3121-34



Kudelko M, Brault JB, Kwok K., Li MY, Pardigon N, Malik Peiris JS, Bruzzone R, Desprès P, Nal B, Wang PG. (2012). Class II ADP-ribosylation factors are required for efficient secretion of dengue viruses. J.Biol.Chem. 287: 767-77

 

Patramool S, Choumet  V, Surasombatpattana P, Sabatier L, Thomas F, Thongrungkiat S, Rabilloud T, Boulanger N, Biron DG, Missé D. (2012). Update on the proteomics of major arthropod vectors of human and animal pathogens. Proteomics. 12:3510-23

 

Tchankouo-Nguetcheu S, Bourguet E, Lenormand P, Rousselle JC, Namane A, Choumet V. (2012). Infection by chikungunya virus modulates the expression of several proteins in Aedes aegypti salivary glands. Parasit Vectors 5:264. doi: 10.1186/1756-3305-5-264.

 


2011

 

Desprès P (2011). Sur le risque de propagation de la dengue et du chikungunya en Europe du Sud. Les Feuillets de Biologie (in French) Vol.III n°304, 39-51



Brault JB, Kudelko M, Vidalain PO, Tangy F, Desprès P, Pardigon N. (2011). The interaction of flavivirus M protein with light chain Tctex-1 of human dynein plays a role in late stages of virus replication. Virology 417:369-78



Warter L, Lee CY, Thiagarajan R, Grandadam M, Lebecque S, Lin RT, Bertin-Maghit S, Ng LF, Abastado JP, Desprès P, Wang CI, Nardin A. (2011). Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency. J Immunol.186:3258-64



Surasombatpattana P, Hamel R, Patramool S, Luplertlop N, Thomas F, Desprès P, Briant L, Yssel H, Missé D. (2011). Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses. Infect Genet Evol. 11:1664-73



Simon-Chazottes D, Frenkiel MP, Montagutelli X, Guénet JL, Desprès P, Panthier JJ. (2011). Transgenic expression of full-length 2',5'-oligoadenylate synthetase 1b confers to BALB/c mice resistance against West Nile virus-induced encephalitis. Virology 417:147-53.



Grandadam M, Caro V, Plumet S, Thiberge JM, Souarès Y, Failloux AB, Tolou HJ, Budelot M, Cosserat D, Leparc-Goffart I, Desprès P. (2011). Chikungunya virus, southeastern France. Emerg Infect Dis. 17:910-3.



Kristiansen H, Gad HH, Eskildsen-Larsen S, Desprès P, Hartmann R. (2011). The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J Interferon Cytokine Res. 31:41-7. Review.

 

2010

 

Murray KO, Mertens E, Desprès P. (2010). West Nile virus and its emergence in the United States of America. Vet Res. 41:67. Review.



La Ruche G, Souarès Y, Armengaud A, Peloux-Petiot F, Delaunay P, Desprès P, Lenglet A, Jourdain F, Leparc-Goffart I, Charlet F, Ollier L, Mantey K, Mollet T, Fournier JP, Torrents R, Leitmeyer K, Hilairet P, Zeller H, Van Bortel W, Dejour-Salamanca D, Grandadam M, Gastellu-Etchegorry M (2010). First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill. 2010 S15:19676.



Brandler S, Ruffie C, Najburg V, Frenkiel MP, Bedouelle H, Desprès P, Tangy F. (2010). Pediatric measles vaccines expressing a dengue tetravalent antigen elicit neutralizing antibodies against all four dengue viruses. Vaccine 28:6730-9



Mertens E, Kajaste-Rudnitski A, Torres S, Funk A, Frenkiel MP, Iteman I, Khromykh AA, Desprès P. (2010). Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2',5'-oligoadenylate synthetase 1b. Virology 399:176-85

 

2009

 

Bellier B, Huret C, Miyalou M, Desjardins D, Frenkiel MP, Desprès P, Tangy F, Dalba C, Klatzmann D. (2009). DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies. Vaccine 27:5772-80. 



Hershkovitz O, Rosental B, Rosenberg LA, Navarro-Sanchez ME, Jivov S, Zilka A, Gershoni-Yahalom O, Brient-Litzler E, Bedouelle H, Ho JW, Campbell KS, Rager-Zisman B, Desprès P, Porgador A. (2009). NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J Immunol. 183:2610-21.



Coffey LL, Mertens E, Brehin AC, Fernandez-Garcia MD, Amara A, Desprès P, Sakuntabhai A. (2009). Human genetic determinants of dengue virus susceptibility. Microbes Infect.11:143-56. Review.



Bréhin AC, Casadémont I, Frenkiel MP, Julier C, Sakuntabhai A, Desprès P. (2009). The large form of human 2',5'-Oligoadenylate Synthetase (OAS3) exerts antiviral effect against Chikungunya virus. Virology 384:216-22.

 


Pardigon N. (2009). The biology of chikungunya: a brief review of what we still do not know. Pathol Biol. 57:127-32. Review

 


2008

 

Coutant F, Frenkiel MP, Desprès P, Charneau P. (2008). Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine. PLoS One: e3973. 



Kwan WH, Navarro-Sanchez EM, Dumortier H, Decossas M, Vachon H, dos Santos FB, Fridman HW, Rey FA, Harris E, Desprès P, Mueller CG. (2008). Dermal-type macrophages expressing CD209/DC-SIGN show inherent resistance to dengue virus growth. PLoS Negl Trop Dis.: e311.



Ozden S, Lucas-Hourani M, Ceccaldi PE, Basak A, Valentine M, Benjannet S, Hamelin J, Jacob Y, Mamchaoui K, Mouly V, Desprès P, Gessain A, Butler-Browne G, Chrétien M, Tangy F, Vidalain PO, Seidah NG. (2008). Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein. J Biol Chem. 283: 21899-908.

 


Bréhin AC, Mouriès J, Frenkiel MP, Dadaglio G, Desprès P, Lafon M, Couderc T. (2008). Dynamics of immune cell recruitment during West Nile encephalitis and identification of a new CD19+B220-BST-2+ leukocyte population. J Immunol. 180: 6760-7.

 

 
Couderc T, Chrétien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, Desprès P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M. (2008). A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog. :e29.



Bréhin AC, Rubrecht L, Navarro-Sanchez ME, Maréchal V, Frenkiel MP, Lapalud P, Laune D, Sall AA, Desprès P. (2008). Production and characterization of mouse monoclonal antibodies reactive to Chikungunya envelope E2 glycoprotein. Virology 371:185-95.

 

2007

 

Brandler S, Lucas-Hourani M, Moris A, Frenkiel MP, Combredet C, Février M, Bedouelle H, Schwartz O, Desprès P, Tangy F. (2007). Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus. PLoS Negl Trop Dis.: e96.



Vazeille M, Moutailler S, Coudrier D, Rousseaux C, Khun H, Huerre M, Thiria J, Dehecq JS, Fontenille D, Schuffenecker I, Desprès P, Failloux AB. (2007). Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus.PLoS One :e1168.



Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, Rudnicka D, Sol-Foulon N, Le Roux K, Prevost MC, Fsihi H, Frenkiel MP, Blanchet F, Afonso PV, Ceccaldi PE, Ozden S, Gessain A, Schuffenecker I, Verhasselt B, Zamborlini A, Saïb A, Rey FA, Arenzana-Seisdedos F, Desprès P, Michault A, Albert ML, Schwartz O. (2007). Characterization of reemerging chikungunya virus. PLoS Pathog. :e89.



Ozden S, Huerre M, Riviere JP, Coffey LL, Afonso PV, Mouly V, de Monredon J, Roger JC, El Amrani M, Yvin JL, Jaffar MC, Frenkiel MP, Sourisseau M, Schwartz O, Butler-Browne G, Desprès P, Gessain A, Ceccaldi PE. (2007). Human muscle satellite cells as targets of Chikungunya virus infection. PLoS One :e527.

Updated on 13/02/2014

Contact

Flavivirus-Host Molecular Interactions Unit

Institut Pasteur

25, Rue du Docteur Roux

75724 Paris Cedex 15 FRANCE

 

Tel + (33) 1 45 68 87 23

Fax + 33 (0)1 40 61 37 74

Organizer

Access to all events